assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (880229P-10mg), pkg of 1 × 100 mg (880229P-100mg), pkg of 1 × 25 mg (880229P-25mg), pkg of 1 × 50 mg (880229P-50mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
lipid type
polymerizable lipids
click reagents
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(OCCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO/C=C\NC(CCC(N1CC(C=CC=C2)=C2C#CC3=C1C=CC=C3)=O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C
General description
DSPE-PEG(2000)-DBCO是一种功能化的聚乙二醇（PEG）脂质偶联物。
Application
DSPE-PEG（2000）-DBCO已用于通过改进的薄膜水合技术制备肽偶联的荧光纳米颗粒。它也已用于介晶分子的同源锚定。
Packaging
5 mL棕色玻璃螺旋盖小瓶（880229P-50mg）
5 mL棕色玻璃螺旋盖小瓶（880229P-100mg）
5 mL棕色玻璃螺旋盖小瓶（880229P-10mg）
5 mL棕色玻璃螺旋盖小瓶（880229P-25mg）
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
No data available
flash_point_c
No data available
A novel nanoparticle delivery system for targeted therapy of noise-induced hearing loss
Kayyali MN, et al.
J. Controlled Release, 279, 243-250 (2018)
Active nematic emulsions
Guillamat BP, et al.
Science advances, 4(4) (2018)
Active nematic emulsions
Guillamat BP, et al.
Science Advances, 4(4) (2018)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 880229P-100MG | 04061835188024 |
| 880229P-10MG | 04061835188031 |
| 880229P-25MG | 04061835188048 |
| 880229P-50MG | 04061835188055 |